Skip to main content

Peer Review reports

From: Safety, tolerability, pharmacokinetics, and pharmacodynamics of TG103 injection in participants who are overweight or obese: a randomized, double-blind, placebo-controlled, multiple-dose phase 1b study

Original Submission
2 Aug 2023 Submitted Original manuscript
7 Sep 2023 Reviewed Reviewer Report
30 Jan 2024 Author responded Author comments - Diaozhu Lin
Resubmission - Version 2
30 Jan 2024 Submitted Manuscript version 2
31 Jan 2024 Reviewed Reviewer Report
11 Apr 2024 Author responded Author comments - Diaozhu Lin
Resubmission - Version 3
11 Apr 2024 Submitted Manuscript version 3
Publishing
16 Apr 2024 Editorially accepted
29 May 2024 Article published 10.1186/s12916-024-03394-z

You can find further information about peer review here.

Back to article page